Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Read Article
News
2024
2023
Archive
Search news articles
June 12, 2017
NEEDLE-FREE INJECTION – PORTAL PRIME: A DIGITALLY CONTROLLED, CLOUD-INTEGRATED JET INJECTION SYSTEM
June 7, 2017
BIRD ROCK BIO COMPLETES SINGLE ASCENDING DOSE HUMAN CLINICAL TRIAL FOR NAMACIZUMAB; GENERATES SAFETY, TOLERABILITY, AND PHARMACOKINETICS DATA; PREPARES TO INITIATE STUDY IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
May 24, 2017
PIERRE FABRE BUYS UP IGENICA PRECLINICAL I-O MEDS
May 24, 2017
APREA THERAPEUTICS ANNOUNCES FIRST PATIENTS ENROLLED IN PHASE IB/II CLINICAL STUDY OF APR-246 FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME
May 16, 2017
SCIENTIST.COM RAISED $24 MILLION IN EQUITY FINANCING CO-LED BY LEERINK TRANSFORMATION PARTNERS AND 5AM VENTURES.
May 12, 2017
THE AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE PUBLISHES STUDY OF SPYRYX BIOSCIENCES’ SPX-101, A NOVEL ENAC-TARGETED THERAPEUTIC FOR CYSTIC FIBROSIS THAT RESTORES MUCUS TRANSPORT
April 25, 2017
PHASERX RECEIVES POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION FOR PRX-OTC FROM EUROPEAN MEDICINES AGENCY
April 20, 2017
AUDENTES THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
April 20, 2017
FIRST INSTALLATION OF THE WORLD’S MOST RESPONSIVE SMART-TINTING GLASS UNVEILED IN SAN FRANCISCO
April 12, 2017
MILLENDO THERAPEUTICS APPOINTS MARY LYNNE HEDLEY, PH.D. AND CAROLE NUECHTERLEIN, J.D. TO BOARD OF DIRECTORS
« Previous Page
1
…
85
86
87
88
89
…
119
Next Page »